CellCan's First Pancanadian Strategic Forum on Cell & Gene Therapy - From Discovery to Commercialization: The First Pancanadian Strategic Forum on Cell & Gene Therapy will be held on March 9-10, 2017 at the Westin Hotel in Montreal. Bringing together national and international experts, this unique form will:
- highlight the most recent innovations in cell therapy, including cancer immunotherapies
- reveal facilitators and barriers to cell and gene therapy translation in Canada
- identify lessons learned and the promising technologies in manufacturing
- build on effective commercialization for the benefit of all Canadians
- discuss issues related to regulation.
The event will highlight the expertise of renowned presenters through lectures and discussion panels, but will also build upon the ideas and skills of participants through workshops. The purpose of the forum is therefore to identify concrete courses of action to help stakeholders in the field to be better equipped to deal with this major medical revolution.
Centre for Commercialization of Cancer Immunotherapy-C3i: February 12, 2016 - Charlottetown, PEI - Networks of Centres of Excellence: Today the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, joined by the Honourable Lawrence MacAulay, Minister of Agriculture and Agri-food, and the Honourable Wade MacLauchlan, Premier of Prince Edward Island, announced two significant investments in research commercialization centres, one of which is the Centre for Commercialization of Cancer Immunotherapy (C3i) in Montréal, that will receive funding of $15 million over five years to develop, translate and commercialize cancer immunotherapy. (Read more...)
Dr. Claude Perreault, winner of the 2015 Prix Michel-Sarrazin: Dr. Claude Perreault, principal investigator at the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal, professor in the Department of Medicine at the University’s Faculty of Medicine and hematologist at Maisonneuve-Rosemont Hospital, is the winner of the 2015 Prix Michel-Sarrazin. The award is presented annually by the Club de recherches cliniques du Québec to a veteran Québec scientist who, through his or her dynamism and productivity, has contributed in an important way to the advancement of biomedical research. (Read more...)
Dr. Claude Perreault and his team's work on MiHAs, part of the Top 10 Canadian Cancer Society-funded research of 2014: Harnessing the immune system's powerful ability to fight cancer, Dr. Claude Perreault in Montreal has identified new molecules that attract T cells, the body's natural killing machines which help fight off germs and diseases. Dr. Perreault used a new approach to identify molecules that attract the T cell's cancer-fighting abilities. (Read more...)
Diana Paola Granados, winner of a Canada Gairdner Award: Dr. Granados, a postdoctoral fellow at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, is the winner of a prize for a poster presented at the "Genomics: The Power and the Promise" conference organized by Genome Canada and the Gairdner Foundation this past November. The distinction carries a $1,000 cash award. (Read more...)